Skip to main content
XPEV
NYSE Manufacturing

XPENG Robotics Unit Dogotix Raises US$900M at US$6.3B Valuation, Diluting XPENG's Stake to 68.41%

Arie Shkolnikov · Analysis by Wiseek AI
More coverage: Automotive Stocks · Consumer
Sentiment info
Positive
Importance info
8
Price
$11.86
Mkt Cap
$11.729B
52W Low
$11.49
52W High
$28.235
52W Position info
3.2% above low
Off High info
58% below high
Rel. Volume info
1.3× avg
Market data snapshot near publication time

XPEV is trading near its 52-week low of $11.49 (3.2% above the low).

Summary

XPENG's robotics subsidiary Dogotix raised US$900 million at a US$6.3 billion post-money valuation from IDG Capital, Alibaba, Tencent, and Gaorong Ventures, diluting XPENG's stake to 68.41% and granting investors redemption rights if no IPO occurs within seven years.


Key Events · Financing and Capital Events · XPEV

  • Dogotix Raises US$900M Series A

    XPENG's robotics subsidiary Dogotix secured US$900 million: US$600M from IDG Capital, Alibaba, Tencent, and Gaorong Ventures; US$200M from XPENG; and US$100M from CEO Xiaopeng He and co-president Dr. Hongdi Brian Gu.

  • US$6.3B Post-Money Valuation

    The financing implies a US$5 billion pre-transaction and US$6.3 billion post-transaction valuation for Dogotix, validating the humanoid robotics business as a distinct asset.

  • XPENG Stake Dilutes to 68.41%

    Assuming full subscription, warrant exercise, and equity incentive plan utilization, XPENG's equity interest in Dogotix falls from 100% to approximately 68.41%, though Dogotix remains a consolidated subsidiary.

  • Redemption Rights Create Contingent Liability

    Investors can force XPENG to redeem their shares at the higher of 120% of purchase price or 100% plus 8% compound annual interest if Dogotix fails to complete a qualified IPO within seven years.


Analysis · XPEV · Manufacturing

XPENG's wholly-owned robotics subsidiary Dogotix has secured US$900 million in Series A financing led by IDG Capital with participation from Alibaba, Tencent, and Gaorong Ventures, valuing Dogotix at US$6.3 billion post-transaction. The deal includes US$600 million from external investors, US$200 million from XPENG itself, and US$100 million from CEO Xiaopeng He and co-president Dr. Hongdi Brian Gu, who also receive warrants exercisable for up to US$500 million in additional shares. Critically, the investors receive redemption rights requiring XPENG to buy back their shares at 120% of purchase price (or 100% plus 8% compound annual interest) if Dogotix fails to complete a qualified IPO within seven years — a significant contingent liability for XPENG. XPENG's stake in Dogotix will dilute from 100% to approximately 68.41% assuming full warrant exercise and equity incentive plan utilization, though Dogotix remains consolidated. The deal validates the robotics business at a substantial valuation but introduces meaningful dilution and a potential future cash obligation.

How filings like this one have moved

In the 30 days to Nov 17, 2026, 48.3% of the 2133 measured filings Wiseek scored 8 moved their stock by 5% or more by the next session's close. The median move was -0.28%. These are measured outcomes after filings of this importance, not a forecast for this one.

Measured one observation per ticker per day, after exclusions. Current figures: Filing Impact Tracker · open dataset

At the time of this filing, XPEV was trading at $11.86 on NYSE in the Manufacturing sector, with a market capitalization of approximately $11.7B. The 52-week trading range was $11.49 to $28.24. This filing was assessed with positive market sentiment and an importance score of 8 out of 10.

View Main SEC Filing

Price Chart

Share this article

Copied!

XPEV - Latest Insights

XPEV
Nov 16, 2026, 6:03 PM EST
Source: GlobeNewswire
Importance Score:
8
Price at Filing: $9.67
Real-time Price: $8.16 info
Change: -$1.51 (-16%) info
Market Cap: $8.944B info
XPEV
Nov 16, 2026, 11:53 AM EST
Source: Benzinga
Importance Score:
7
Price at Filing: $9.92
Real-time Price: $8.16 info
Change: -$1.75 (-18%) info
Market Cap: $8.944B info
XPEV
Nov 16, 2026, 6:24 AM EST
Filing Type: 6-K
Importance Score:
8
Price at Filing: $9.73
Real-time Price: $8.16 info
Change: -$1.57 (-16%) info
Market Cap: $8.944B info
XPEV
Nov 02, 2026, 6:49 AM EST
Filing Type: 6-K
Importance Score:
7
Price at Filing: $9.46
Real-time Price: $8.16 info
Change: -$1.30 (-14%) info
Market Cap: $8.944B info
XPEV
Nov 02, 2026, 12:24 AM EST
Source: Seeking Alpha
Importance Score:
7
Price at Filing: $9.01
Real-time Price: $8.16 info
Change: -$0.850 (-9%) info
Market Cap: $8.944B info